Qube Research & Technologies (QRT)
MEDP icon

Qube Research & Technologies (QRT)’s Medpace MEDP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,012
Closed -$3.37M – 3842
2026
Q1 		$3.37M Sell
7,012
-146,673
-95% -$75.1M ﹤0.01% 1868
2025
Q4 		$86.3M Buy
153,685
+78,905
+106% +$44.8M 0.09% 295
2025
Q3 		$38.4M Buy
74,780
+70,186
+1,528% +$30.6M 0.04% 588
2025
Q2 		$1.44M Buy
+4,594
New +$1.38M ﹤0.01% 2326
2024
Q4 		– Sell
-10,624
Closed -$3.55M – 3692
2024
Q3 		$3.55M Sell
10,624
-62,277
-85% -$23.7M 0.01% 1543
2024
Q2 		$30M Sell
72,901
-33,152
-31% -$13.1M 0.05% 457
2024
Q1 		$42.9M Buy
106,053
+72,125
+213% +$25.4M 0.07% 340
2023
Q4 		$10.4M Buy
33,928
+9,594
+39% +$2.59M 0.02% 724
2023
Q3 		$5.89M Buy
24,334
+14,494
+147% +$3.71M 0.02% 863
2023
Q2 		$2.36M Sell
9,840
-11,108
-53% -$2.31M 0.01% 982
2023
Q1 		$3.94M Buy
20,948
+6,823
+48% +$1.41M 0.02% 737
2022
Q4 		$3M Buy
+14,125
New +$2.82M 0.02% 803
2021
Q3 		– Sell
-3,209
Closed -$567K – 2556
2021
Q2 		$567K Buy
3,209
+555
+21% +$95.8K 0.01% 1225
2021
Q1 		$435K Buy
2,654
+799
+43% +$122K 0.01% 1255
2020
Q4 		$258K Sell
1,855
-12,153
-87% -$1.53M ﹤0.01% 1416
2020
Q3 		$1.56M Buy
14,008
+8,000
+133% +$925K 0.02% 699
2020
Q2 		$559K Buy
+6,008
New +$511K 0.01% 1073

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MEDP Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Medpace (MEDP) in Q2 2026, closing a stake of 7,012 shares — an estimated $3.37M sold.

Qube Research & Technologies (QRT) first reported a position in MEDP in Q2 2020 and held it in 17 quarters. The position peaked at $86.3M in Q4 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 7,012 Medpace shares in Q2 2026, an estimated $3.37M.
  • Qube Research & Technologies (QRT) first reported a position in Medpace in Q2 2020 and held it in 17 quarters.
  • Qube Research & Technologies (QRT)'s Medpace position peaked at $86.3M in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.